Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) EBIT Margin (2023 - 2025)

Historic EBIT Margin for Praxis Precision Medicines (PRAX) over the last 2 years, with Q4 2024 value amounting to 856.97%.

  • Praxis Precision Medicines' EBIT Margin rose 45422500.0% to 856.97% in Q4 2024 from the same period last year, while for Sep 2025 it was 3927.51%, marking a year-over-year increase of 62914900.0%. This contributed to the annual value of 2340.29% for FY2024, which is 28241200.0% up from last year.
  • As of Q4 2024, Praxis Precision Medicines' EBIT Margin stood at 856.97%, which was up 45422500.0% from 18819.54% recorded in Q3 2024.
  • Praxis Precision Medicines' 5-year EBIT Margin high stood at 856.97% for Q4 2024, and its period low was 18819.54% during Q3 2024.